查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553644

儿科心臟肿瘤诊断市场规模、份额、趋势分析报告：按肿瘤、类型、最终用途、地区、细分市场预测，2024-2030 年

Pediatric Cardiac Tumor Diagnostic Market Size, Share & Trend Analysis Report By Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors), By Type (Echocardiography, MRI), By End-use, By Region, and Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

儿科心臟肿瘤诊断市场的成长和趋势：

Grand View Research, Inc.最新报告预测，到2030年，全球儿科心臟肿瘤诊断市场规模预计将达到10.6亿美元，2024年至2030年复合年增长率为8.03%。

该市场的成长归功于医疗技术的不断提高和进步。随着儿童先天性心臟疾病和肿瘤的增加，对准确、早期诊断工具的需求迅速增加。先进的影像技术和改进的生物标记等技术创新提高了诊断能力，可以更早检测和更好地管理儿童心臟肿瘤。例如，2021 年 6 月，西班牙国家循环系统研究中心和飞利浦合作开发了一种用于研究目的的超快心臟 MRI通讯协定。该合作伙伴关係旨在增强未来的临床功能，包括肿瘤学研究的进展。随着医疗保健提供者寻求更有效的解决方案来诊断和治疗这些罕见疾病，此类创新可以改善患者的治疗效果并推动市场成长。

此外，技术进步对儿科心臟肿瘤诊断市场产生重大影响并推动其成长。高解析度 MRI 和电脑断层扫描技术的发展使得以更高的精度和细节对儿童心臟肿瘤进行成像成为可能。这些影像方式增强了早期发现和准确诊断，对于有效治疗至关重要。此外，将人工智慧 (AI) 整合到诊断过程中，透过分析复杂的影像资料进一步提高准确性和效率。随着这些技术的发展，透过提供更好的诊断工具、改善患者的治疗效果以及降低与儿科心臟肿瘤治疗相关的医疗保健成本，预计市场成长将会扩大。

对儿科医疗保健的投资和对肿瘤学研究的资助是推动市场成长的关键因素。增加对儿科医疗保健的投资将确保先进诊断工具和技术的发展，例如高解析度 MRI 和电脑断层扫描，这对于准确检测和监测儿童心臟肿瘤至关重要。例如，2024 年 6 月，亚马逊网路服务公司投资 1,000 万美元来推进儿科医学研究并增进对包括肿瘤在内的罕见疾病的了解。这些投资不仅将加速技术进步，还将透过增加创新诊断解决方案的可用性来提高医疗保健品质并扩大市场。

此外，公众和专业人士对儿科癌症护理了解的提高将增加对先进诊断工具和早期检测方法的需求。例如，国际儿童癌症日是一项全球倡议，旨在提高对儿童癌症的认识，并向受影响的儿童、青少年、倖存者及其家人表示支持。随着意识的提高，专业影像技术和治疗的市场也在扩大，从而导致该领域的投资和创新增加。人们对儿科医学日益增长的兴趣将支持市场扩张并改善患有心臟肿瘤的儿童的治疗结果。

儿科心臟肿瘤诊断市场报告亮点

  • 由于影像技术的进步、认识的提高和诊断工具的改进，原发性心臟肿瘤部分在 2023 年占据最大份额，为 84.81%。这些因素有利于早期发现和治疗，进而促进市场扩张。
  • 超音波心动图领域因其非侵入性、先进的成像能力以及提高的诊断准确性，在2023年占据最大份额，达到60.76%。飞利浦和通用电气医疗保健等主要企业正在利用先进技术推动创新，以改善早期检测和治疗结果。
  • 到2023年，在医疗基础设施改善、资金筹措和投资增加的推动下，医院和诊所部门将占据最大份额，达到73.89%。增强的设施和资源支持先进的诊断技术，从而更好地检测和管理小儿心臟肿瘤。
  • 北美地区主导全球儿科心臟肿瘤诊断市场，2023年占36.44%的销售份额。包括先进成像技术和研究在内的策略开拓和创新正在推动该地区的市场成长并提高诊断准确性。
  • 儿科心臟肿瘤诊断市场竞争激烈，主要企业占有重要地位。主要企业正在采取各种策略，包括新产品开发、收购、联盟、併购和区域扩张，以满足客户未满足的需求。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章儿科心臟肿瘤诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 儿科心臟肿瘤诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章小儿心臟肿瘤诊断市场：依肿瘤类型估计及趋势分析

  • 细分仪表板
  • 儿科心臟肿瘤诊断市场：肿瘤变化分析
  • 按肿瘤分类的展望：儿科心臟肿瘤诊断市场
  • 2018-2030年市场规模、预测及趋势分析
  • 原发性心臟肿瘤
  • 续发性心臟肿瘤

第五章儿科心臟肿瘤诊断市场：按类型估计和趋势分析

  • 细分仪表板
  • 儿科心臟肿瘤诊断市场：类型变异分析
  • 儿科心臟肿瘤诊断市场：按类型分類的展望
  • 2018-2030年市场规模、预测及趋势分析
  • 心臟超音波图
  • 磁振造影(MRI)
  • 电脑断层扫描 (CT) 扫描
  • 其他的

第六章儿科心臟肿瘤诊断市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 儿科心臟肿瘤诊断市场：最终用途变化分析
  • 儿科心臟肿瘤诊断市场：最终用途展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院和诊所
  • 卫生署、政府
  • 其他的

第七章儿科心臟肿瘤诊断市场：区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 市场参与企业分类
  • 主要企业简介
    • GE HealthCare
    • Siemens Healthineers AG
    • CANON MEDICAL SYSTEMS CORPORATION
    • Boston Scientific Corporation
    • Lantheus
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Medtronic
Product Code: GVR-4-68040-434-5

Pediatric Cardiac Tumor Diagnostic Market Growth & Trends:

The global pediatric cardiac tumor diagnostic market size is anticipated to reach USD 1.06 billion by 2030 and is projected to grow at a CAGR of 8.03% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing awareness and advancements in medical technology. With the rise in the prevalence of congenital heart conditions and tumors among children, the demand for accurate and early diagnostic tools has surged. Technological innovations, such as advanced imaging techniques and improved biomarkers, have enhanced diagnostic capabilities, allowing for earlier detection and better management of pediatric cardiac tumors. For instance, in June 2021, the Spanish National Center for Cardiovascular Research and Philips teamed up to develop an ultra-fast cardiac MRI protocol for research purposes. This collaboration aims to enhance clinical practice in the future, including advancements in oncology research. These innovations improve patient outcomes and drive market growth as healthcare providers seek more effective solutions for diagnosing and treating these rare conditions.

Moreover, technological advancements significantly impact the market for pediatric cardiac tumor diagnostics, driving its growth. The development of high-resolution MRI and CT scan technologies allows for more accurate and detailed imaging of cardiac tumors in children. These imaging modalities enhance early detection and precise diagnosis, which are crucial for effective treatment. In addition, the integration of artificial intelligence (AI) into diagnostic processes is further improving accuracy and efficiency by analyzing complex imaging data.As these technologies evolve, they are expected to expand market growth by providing better diagnostic tools, improving patient outcomes, and reducing healthcare costs associated with pediatric cardiac tumor care.

The investment in pediatric care and funding for oncology research are pivotal factors driving the growth of the market. Increased investment in pediatric healthcare ensures the development of advanced diagnostic tools and technologies, such as high-resolution MRI and CT scans, which are crucial for accurately detecting and monitoring cardiac tumors in children. For instance,in June 2024, Amazon Web Services Inc. invested USD 10 million to advance research in pediatric healthcare and enhance the understanding of rare diseases, including tumors. These investments not only accelerate technological advancements but also expand the market by improving the quality of care and increasing the availability of innovative diagnostic solutions.

Furthermore, increased public and professional understanding of pediatric oncology care drives demand for advanced diagnostic tools and early detection methods. For instance, International Childhood Cancer Day is a worldwide initiative aimed at raising awareness about childhood cancer and showing support for affected children, adolescents, survivors, and their families. As awareness grows, so does the market for specialized imaging technologies and treatments, leading to more investment and innovation in this field. This heightened focus on pediatric care supports market expansion and improves outcomes for children with cardiac tumors.

Pediatric Cardiac Tumor Diagnostic Market Report Highlights:

  • The primary cardiac tumors segment held the largest share, 84.81%, in 2023due to advancements in imaging technologies, increased awareness, and improved diagnostic tools. These factors enhance early detection and treatment, driving market expansion.
  • The echocardiography segment held the largest share, 60.76%, in 2023 due to its noninvasive nature, advanced imaging capabilities, and enhanced diagnostic accuracy. Key players like Philips and GE Healthcare drive innovation with advanced technology, improving early detection and treatment outcomes.
  • The hospitals and clinics segment held the largest share, 73.89%, in 2023, fueledby improved healthcare infrastructure, increased funding, and investment. Enhanced facilities and resources support advanced diagnostic technologies, leading to better detection and management of pediatric cardiac tumors.
  • The North America region dominated the overall global market for pediatric cardiac tumor diagnosticsand accounted for the 36.44% revenue share in 2023. Strategic development and innovation, including advanced imaging technologies and research, drive market growth and enhance diagnostic accuracy in this region.
  • The competitive scenario in the pediatric cardiac tumor diagnostic market is high, with key players holding significant positions. The major companies are undertaking various strategies, such as new product development, acquisitions, collaborations, mergers, and regional expansion, to serve their customers' unmet needs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Tumor
    • 1.2.2. Type
    • 1.2.3. End use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Tumor outlook
    • 2.2.2. Type outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pediatric Cardiac Tumor Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pediatric Cardiac Tumor Diagnostic Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pediatric Cardiac Tumor Diagnostic Market: Tumor Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pediatric Cardiac Tumor Diagnostic Market: Tumor Movement Analysis
  • 4.3. Pediatric Cardiac Tumor Diagnostic Market by Tumor Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Primary Cardiac Tumors
    • 4.5.1. Primary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Secondary Cardiac Tumors
      • 4.5.2.1. Secondary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric Cardiac Tumor Diagnostic Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pediatric Cardiac Tumor Diagnostic Market: Type Movement Analysis
  • 5.3. Pediatric Cardiac Tumor Diagnostic Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Echocardiography
    • 5.5.1. Echocardiography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Magnetic Resonance Imaging (MRI)
    • 5.6.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Computed Tomography (CT) Scan
    • 5.7.1. Computed Tomography (CT) Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pediatric Cardiac Tumor Diagnostic Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pediatric Cardiac Tumor Diagnostic Market: End Use Movement Analysis
  • 6.3. Pediatric Cardiac Tumor Diagnostic Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals and Clinics
    • 6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Government Health Department
    • 6.6.1. Government Health Department Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pediatric Cardiac Tumor Diagnostic Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. GE HealthCare
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Siemens Healthineers AG
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. CANON MEDICAL SYSTEMS CORPORATION
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Boston Scientific Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Lantheus
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Bio-Rad Laboratories, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Abbott
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. F. Hoffmann-La Roche Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Medtronic
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 4. Global pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America pediatric cardiac tumor diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 8. North America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 9. North America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 10. U.S. pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 11. U.S. pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 12. U.S. pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Canada pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 14. Canada pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 15. Canada pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Mexico pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 17. Mexico pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 18. Mexico pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 19. Europe pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 21. Europe pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 22. Europe pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 23. UK pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 24. UK pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 25. UK pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Germany pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 27. Germany pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 28. Germany pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 29. France pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 30. France pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 31. France pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 32. Italy pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 33. Italy pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 34. Italy pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Spain pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 36. Spain pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 37. Spain pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Denmark pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 39. Denmark pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 40. Denmark pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 41. Norway pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 42. Norway pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 43. Norway pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Sweden pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 45. Sweden pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 46. Sweden pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Japan pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 52. Japan pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 53. Japan pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 54. China pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 55. China pediatric cardiac tumor diagnostic market, by type 2018 - 2030 (USD Million)
  • Table 56. China pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 57. India pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 58. India pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 59. India pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Australia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 61. Australia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 62. Australia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 63. South Korea pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 64. South Korea pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 65. South Korea pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Thailand pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 67. Thailand pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 68. Thailand pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 69. Latin America pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 71. Latin America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 72. Latin America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Brazil pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 74. Brazil pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 75. Brazil pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 76. Argentina pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 77. Argentina pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 78. Argentina pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 83. South Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 84. South Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 85. South Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 89. UAE pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 90. UAE pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 91. UAE pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 93. Kuwait pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Pediatric cardiac tumor diagnostic market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Pediatric cardiac tumor diagnostic market, tumor outlook key takeaways (USD Million)
  • Fig. 12 Pediatric cardiac tumor diagnostic market: tumor movement analysis (USD Million), 2023 & 2030
  • Fig. 13 Primary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Secondary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Pediatric cardiac tumor diagnostic market, type outlook key takeaways (USD Million)
  • Fig. 16 Pediatric cardiac tumor diagnostic market: type movement analysis (USD Million), 2023 & 2030
  • Fig. 17 Echocardiography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Magnetic Resonance Imaging (MRI) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Computed Tomography (CT) scan market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pediatric cardiac tumor diagnostic market, end use outlook key takeaways (USD Million)
  • Fig. 22 Pediatric cardiac tumor diagnostic market: end use movement analysis (USD Million), 2023 & 2030
  • Fig. 23 Hospitals and clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Government health department market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Pediatric cardiac tumor diagnostic market: regional key takeaways (USD Million)
  • Fig. 27 Pediatric cardiac tumor diagnostic market: regional outlook, 2023 & 2030, USD Million
  • Fig. 28 North America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 List of key emerging company's/type disruptors/innovators